A startup spawned from a lab at the University of California, Berkeley has won investor support to work on its patented needle-free injector, which it hopes can make therapies that traditionally ...
The advent of large-protein biologics enabled the creation of breakthrough treatments for many chronic conditions, and this represents a multi-billion-dollar market. However, challenges exist with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results